Citigroup
ABVX

Citigroup’s Abivax ABVX Stock Holding History

Citigroup’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
10,061
+8,332
+482% +$943K ﹤0.01% 3241
2026
Q1 		$193K Buy
1,729
+55
+3% +$6.51K ﹤0.01% 4022
2025
Q4 		$226K Buy
1,674
+1,623
+3,182% +$177K ﹤0.01% 3942
2025
Q3 		$4.33K Sell
51
-170,682
-100% -$10.5M ﹤0.01% 5268
2025
Q2 		$1.31M Sell
170,733
-13,506
-7% -$88K ﹤0.01% 3000
2025
Q1 		$1.15M Buy
+184,239
New +$1.25M ﹤0.01% 3145

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup's ABVX Position: Q2 2026 in Review

Citigroup increased its Abivax (ABVX) stake by 482% in Q2 2026, buying an estimated $943K and bringing the position to 10,061 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #3241.

Citigroup first reported a position in ABVX in Q1 2025 and has held it in 6 quarters since. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Citigroup held 10,061 shares of Abivax worth $1.34M as of Q2 2026.
  • Citigroup bought 8,332 Abivax shares in Q2 2026, an estimated $943K.
  • Abivax made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3241 holding.
  • Citigroup first reported a position in Abivax in Q1 2025 and has held it in 6 quarters since.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.